MENU

Radiation Oncology Resident Research Publications

The following are publications in peer-reviewed journals or book chapters written by Fox Chase residents during their residency in the past 5 years on which they were the first authors:

 

2017

Churilla TM, Ballman KV, Brown PD, Twohy EL, Jaeckle K, Farace E, Cerhan JH, Anderson SK, Carrero XW, Garces YI, Barker FG, Deming R, Dixon JG, Burri SH, Chung C, Menard C, Stieber VW, Pollock BE, Galanis E, Buckner JC, Asher AL. Stereotactic radiosurgery with or without whole brain radiotherapy for limited brain metastases: a secondary analysis of the NCCTG N0574 (Alliance) randomized controlled trial. The International Journal of Radiation Oncology, Biology, Physics, 2017

Churilla TM, Handorf E, Collette S, Collette L, Dong Y, Aizer A, Kocher M, Soffietti R, Alexander BM, Weiss SE.  Whole brain radiotherapy after stereotactic radiosurgery or surgical resection among patients with 1-3 brain metastases and favorable prognoses: A secondary analysis of EORTC 22952-26001. Annals of Oncology, 2017.

Dong Y, Li T, Churilla TM, Shaikh T, Sigurdson ER, Bleicher RJ, Weiss SE, Hayes SB, Anderson PR "Impact of Rheumatoid Arthritis on Radiation-related Toxicity and Cosmesis in Breast Cancer Patients: A Contemporary Matched Pair Analysis" Breast Cancer Res Treat. 2017 Aug 19. doi: 10.1007/s10549-017-4438-7 (PMID 28825145)

Dong Y, Zaorsky NG, Li T, Churilla TM, Viterbo R, Sobczak ML, Smaldone MC, Chen DY, Uzzo RG, Hallman MH, Horwitz EM “Effects of interruptions of external beam radiation therapy for prostate cancer” Accepted to Journal of Medical Imaging and Radiation Oncology, Aug 2017

Dong Y, Stock-Martineau S, Soulières D, Galloway T Chapter “Therapies Targeting VEGF/Angiogenesis and Other Novel Agents for SCCHN” Head and Neck Cancers: Evidence-based Treatment, Demos Medical Publishing, LLC, New York, 2017

Dong Y, Churilla TM Chapter “Extremity sarcoma” Radiation Oncology Question-based Review, 3rd edition, Wolters Kluwer, 2017

Dong Y, Ridge JA, Li T, Lango MN, Churilla TM, Bauman JR, Galloway TJ “Long-term Toxicities in 10-year Survivors of Radiation Treatment for Head and Neck Cancer” Oral Oncol. 2017 Aug;71:122-128 (PMID: 28688679)

Dong Y, Ruth KJ, Churilla TM, Viterbo R, Sobczak ML, Smaldone MC, Chen DY, Uzzo RG, Hallman MH, Horwitz EM “The need for androgen deprivation therapy in patients with intermediate-risk prostate cancer treated with dose-escalated external beam radiation therapy” Can J Urol. 2017 Feb;24(1):8656-8662 (PMID: 28263132)

Shaikh T, Handorf EA, Meyer JE, Hall MJ, Esnaola NF. Mismatch Repair Deficiency Testing in Patients With Colorectal Cancer and Nonadherence to Testing Guidelines in Young Adults.JAMA Oncol. 2017 Nov 9:e173580. doi: 10.1001/jamaoncol.2017.3580. [Epub ahead of print] PMID: 29121143

Shaikh T, Meyer JE, Horwitz EM.  Optimal Use of Combined Modality Therapy in the Treatment of Esophageal Cancer.Surg Oncol Clin N Am. 2017 Jul;26(3):405-429. doi: 10.1016/j.soc.2017.01.009. Epub 2017 May 11. Review. PMID: 28576180

Shaikh T, Li T, Handorf EA, Johnson ME, Wang LS, Hallman MA, Greenberg RE, Price RA Jr, Uzzo RG, Ma C, Chen D, Geynisman DM, Pollack A, Horwitz EM.    Long-Term Patient-Reported Outcomes From a Phase 3 Randomized Prospective Trial of Conventional Versus Hypofractionated Radiation Therapy for Localized Prostate Cancer. Int J Radiat Oncol Biol Phys. 2017 Mar 15;97(4):722-731. doi: 10.1016/j.ijrobp.2016.12.034. Epub 2016 Dec 28. PMID: 28244407

Zaorsky NG, Lee CT, Zhang E, Galloway TJ. Hypofractionated radiation therapy has favorable cosmesis for indolent skin cancers. Radiother Oncol. 2017.

Zaorsky NG, Showalter TN, Ezzel GA, Nguyen PL, Assimos DG, D’Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLauglin PW, Movsas B, Prestige BR, Taira AV, Vapiwala N, Davis BJ. ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part I of II.   Adv Radiat Oncol. 2017

Zaorsky NG, Showalter TN, Ezzel GA, Nguyen PL, Assimos DG, D’Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLauglin PW, Movsas B, Prestige BR, Taira AV, Vapiwala N, Davis BJ. ACR Appropriateness Criteria® external beam radiation therapy treatment planning for clinically localized prostate cancer, part II of II.   Adv Radiat Oncol. 2017

Zaorsky NG, Davis BJ, Nguyen PL, Showalter TN, Hoskin PJ, Yoshioka T, Morton G, Horwitz EM. Evolution of brachytherapy for prostate cancer. Nat Rev Urol. 2017.

Zaorsky NG, Williams GR, Barta SK, Esnaola NF, Kropf P, Hayes SB, Meyer JE. Splenic irradiation for splenomegaly: a systematic review. Cancer Treat Rev. 2017. 22;53:47-52.

 

2016

Avkshtol V, Dong Y, Hayes SB, et al. A comparison of robotic arm versus gantry linear accelerator stereotactic body radiation therapy for prostate cancer. Res Rep Urol. 2016;8:145-58.

Churilla TM, Egleston B, Murphy C, Sigurdson E, Hayes S, Goldstein L, Bleicher R. Patterns of Multidisciplinary Care in the Management of Non-Metastatic Invasive Breast Cancer in the United States Medicare Patient. Breast Cancer Research and Treatment. 2016, Sep 17. DOI:10.1007/s10549-016-3982-x

Churilla TM, Egleston B, Dong Y, Shaikh, T, Murphy C, Mantia-Smaldone G,  Chu C, Rubin S, Anderson, P. “Disparities in the Management and Outcome of Cervical Cancer in the United States according to Health Insurance Status.”  Gynecologic Oncology.2016, Jun; 141(3) 516-23.  DOI:10.1016/j.ygyno.2016.03.025

Churilla TM, Egleston B, Murphy C, Sigurdson E, Hayes S, Goldstein L, Bleicher R. “Patterns of Multidisciplinary Care in the Management of Non-Metastatic Invasive Breast Cancer in the United States Medicare Patient.” Breast Cancer Research and Treatment. 2016, Sep 17. DOI:10.1007/s10549-016-3982-x

DongY, LiT, ChurillaTM, ViterboR, SobczakM, SmaldoneM, ChenD,  UzzoR, HallmanM, HorwitzEM,  “Effects of Time to Treatment on Biochemical and Clinical Outcomes for Patients with Prostate Cancer Treated with Definitive Radiation”,  Clin Genitourin Cancer. 2016 Oct;14(5):e463-e468. doi: 10.1016/j.clgc.2016.01.014. Epub 2016 Feb 10.

Leachman BK, Galloway TJ. Management of Sarcoma: The Role for Radiation Therapy. Surgical Clinics of North America (2016). 96(5), 1127-1139.

Murphy CT, Galloway TJ, Handorf EA, Egleston BL, Wang LS, Mehra R, Flieder DB, Ridge JA.  “Survival Impact of Increasing Time to Treatment Initiation for Patients With Head and Neck Cancer in the United States”. J Clin Oncol. 2016 Jan 10;34(2):169-78. doi: 10.1200/JCO.2015.61.5906.

Shaikh T, Handorf EA, Murphy CT, Mehra R, Ridge JA, Galloway TJ. “The impact of radiation treatment time on survival in patients with head and neck cancer.”  Int J Radiat Oncol Biol Phys. Accepted. Manuscript in Print.

Shaikh T, Churilla TM, Murphy CT, Zaorsky NG, Haber A, Hallman M, Meyer JE.  “Absence of pathological proof of cancer associated with improved outcomes in early stage lung cancer.” J Thorac Oncol. 2016 Apr 19. (PMID: 27109322)

Shaikh T, Churilla TM, Mantia-Smaldone GM, Chu C, Rubin SC, Anderson PR. “The role of adjuvant radiation in lymph node positive endometrial adenocarcinoma.” Gynecol Oncol. 2016 Apr 14. (PMID: 27090796)

Shaikh T, Churilla TM, Monpara P, Scott WJ, Cohen SJ, Meyer JE. “Risk of radiation pneumonitis in patients receiving taxane-based tri-modality therapy for locally advanced esophageal cancer.” Pract Radiat Oncol. 2016 Feb 27. (PMID: 27025161)

Shaikh T, Li T, Murphy CT, Zaorsky NZ, Bleicher RJ, Sigurdson ER, Carlson R, Hayes SB, Anderson PR. “Importance of surgical margin status in ductal carcinoma in situ.” Clin Breast Cancer. 2016 Feb 12. (PMID: 26952595)

Shaikh T, Wang LS, Ruth K, Hallman M, Chen DY, Greenberg RE, Li J, Crawford K, Horwitz EM. “Trainee involvement does not impact outcomes in low dose rate brachytherapy for prostate cancer.” Brachytherapy. 2016 Jan 29. (PMID: 26832675)

Wang LS, Murphy CT, Handorf EA, Freedman G, Johnson ME, Shaikh T, Hayes SB, Bleicher R, Goldstein L, Anderson PA. Long-term Toxicity and Outcomes of Hypofractionated Radiation Therapy With an Incorporated Boost for Early-Stage Breast Cancer. Manuscript in preparation.

Zaorsky NG, Churilla TM, Ruth K, Hayes SB, Sobczak ML, Hallman MA, Smaldone MC, Chen DYT, Horwitz EM. Men’s health supplement use and outcomes in men receiving definitive intensity-modulated radiation therapy for localized prostate cancer. Amer J Clin Nutr. 2016

Zaorsky NG, Churilla TM, Egleston BL, Fisher SG, Ridge JA, Horwitz EM, Meyer JE.  Causes of death among cancer patients.  Annals of Oncol. 2016.

Zaorsky NG, Ricco AG, Churilla TM, Horwitz EM, Den RB. ASTRO APEx® and RO-ILS™ are applicable to medical malpractice in radiation oncology. Future Oncol. 2016 Jul 29.

Zaorsky NG, Shaikh T, Murphy CT, Hallman MA, Hayes SB, Sobczak ML, Horwitz EM.  Comparison of outcomes and toxicities among radiation therapy treatment options for prostate cancer.  Cancer Treat Rev. 2016. 48:50-60.

Zaorsky NG, Showalter TN, Ezzel GA, Nguyen PL, Assimos DG, D’Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLauglin PW, Movsas B, Prestige BR, Taira AV, Vapiwala N, Davis BJ. External beam radiation therapy for clinically localized prostate cancer, part I of II: Target volumes and treatment planning.  Applied Rad Onc.  2016. (in press)

Zaorsky NG, Showalter TN, Ezzel GA, Nguyen PL, Assimos DG, D’Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLauglin PW, Movsas B, Prestige BR, Taira AV, Vapiwala N, Davis BJ. External beam radiation therapy for clinically localized prostate cancer, part II of II: Treatment delivery. Applied Rad Onc. 2016.

Zaorsky NG, Egleston BL, Horwitz EM, Dicker AP, Nguyen PL, Showalter TN, Den RB. The missing pieces in reporting of randomized controlled trials of external beam radiation therapy dose escalation for prostate cancer Am J Clin Oncol. 2016

Zaorsky NG, Keith SW, Shaikh T, Nguyen PL, Horwitz EM, Dicker AP, Den RB. Impact of Radiation Therapy Dose Escalation on Prostate Cancer Outcomes and Toxicities. Am J Clin Oncol. 2016 Mar 24

Zaorsky NG, Wang HH, Cui YL, Lan J, Deng L, Zeng XL, Wu ZQ, Tao Z, Guo WH, Wang QX, Zhao LJ, Yuan ZY, Lu Y, Wang P, Meng MB.  Mesenchymal stem cells generate pericytes to promote tumor recurrence via vasculogenesis after stereotactic body radiation therapy. Cancer Lett. 2016 Mar 17. pii: S0304-3835(16)30101-X. doi: 10.1016/j.canlet.2016.02.033.

Zaorsky NG, Horwitz EM. Brachytherapy for prostate cancer (Chapter). In: Prostate Cancer: Science and Clinical Practice. 2016. Mydlo JH, Godec CJ (Eds.). 399-412. ISBN: 9780128000779.

Zaorsky NG, Ruth K, Shaikh T, Smaldone MC, Hallman MA, Slifker M, Viterbo R, Chen DY, Hayes, SB, Sobczak ML, Horwitz EM. Prostate Cancer Patients With Unmanaged Diabetes or Receiving Insulin Experience Inferior Outcomes and Toxicities After Treatment With Radiation Therapy.  Clin Genitourinary Cancer. 2016.

Zaorsky NG, Williams GR, Barta SK, Esnaola NF, Kropf P, Hayes SB, Meyer JE. Splenic irradiation for splenomegaly: a systematic review. Cancer Treat Rev. 2016.

2015

M. Johnson, T. Li, A. Kutikov, M. Sobczak, M. Smaldone, E. Horwitz.  “Toxicity Analysis of Lymph Node Irradiation for Prostate Cancer Patients Treated with IMRT.”  Practical Cancer and Prostatic Disease, manuscript in review.

Martin JM, Li T, Johnson ME, Murphy CT, Howald AG, Smaldone MC, Kutikov A, Chen DYT, Viterbo R, Greenberg RE, Uzzo RG, Horwitz EM, (2014) “Utilization of Post-Prostatectomy Radiation Therapy at an NCI-Designated Comprehensive Cancer Center” Published in Journal of the National Comprehensive Cancer Network (JNCCN), 2015, PMID# 25964638

Martin JM, Galloway TJ, “Evaluation and Management of Head and Neck Squamous Cell Carcinoma of Unknown Primary,” Surgical Oncology Clinics of North America July 2015 24(3); 579-591 PMID:25979401

Martin JM, Handorf EA, Cherian G, Buyyounouski MK, Chen DY, Kutikov A, Price, RA, Johnson ME, Horwitz EM, “Comparison of Testicular Dose Delivered by Intensity-Modulated Radiation Therapy(IMRT) and Volumetric-Modulated Arc Therapy(VMAT) in Prostate Cancer Patients,” Medical Dosimetry Jan 2015: Epub. PMID: 25595491

Murphy CT, Galloway TJ, Handorf EA, Wang LS, Mehra R, Fleider DB, Ridge JA (2015) “The Survival Impact of Increasing Time to Treatment Initiation for Patients with Head and Neck Cancer in the United States” In Press, Journal of Clinical Oncology

Murphy CT, Devarajan K, Wang LS, Mehra R, Fundakowski C, Ridge JA, Galloway TJ (2015) “Assessment of the Prognostic Utility of Pre-Treatment Tumor Growth Rate as a Temporal Biomarker in Oropharyngeal Cancer Treated with Definitive Radiation Therapy” In Press, Oral Oncology

Murphy CT, Li T, Wang LS, Obeid EI, Bleicher RJ, Eastwick G, Johnson ME, Hayes SB, Weiss SE, Anderson PR “Comparison of Adjuvant Radiation Therapy Alone versus Radiation Therapy and Endocrine Therapy in Elderly Women with Early Stage, Hormone-Receptor Positive Breast Cancer Treated with Breast-Conserving Surgery” Published in Clinical Breast Cancer, 2015, PMID# 25861716

Shaikh T, Wang LS, Egleston B, Burki M, Hoffman JP, Cohen SJ, Meyer JE. “Dosimetric predictors of hematologic toxicity in patients undergoing concurrent gemcitabine-based chemoradiation for localized pancreatic cancer.” Practical Radiation Oncology. Accepted. Manuscript in Press.

Shaikh T, Zaki MA, Dominello MM, Handorf E, Konski AA, Cohen SJ, Shields A, Philip P, Meyer JE.  “Patterns and predictors of failure following tri-modality therapy for locally advanced esophageal cancer.” Acta Oncologica. 2015 Nov 19:1-6. In Press. (PMID: 26581671)

Shaikh T, Thomay A, Ruth KJ, Cohen SJ, Meyer JE. “Association of treatment factors with surgical outcomes in tri-modality therapy for esophageal cancer.” J Surg Oncol. 2015 Oct 2. In Press. (PMID: 26430952)

Shaikh T, Tam TY, Li T, Hayes SB, Goldstein L, Bleicher R, Boraas M, Sigurdson E, Ryan PD, Anderson, PA. “Multifocal and multicentric breast cancer is associated with increased local recurrence regardless of surgery.” Breast J. 2015 Mar-Apr;21(2):121-6. (PMID: 25597248)

Shaikh T, Handorf EA, Murphy CT, Kutikov A, Uzzo RG, Hallman MA, Horwitz EM, Smaldone MC (2015) “Contemporary Trends in the Utilization of Radiation Therapy in Patients with Renal Cell Carcinoma” In Press, Urology

Wang LS, Murphy CT, Ruth KJ, Zaorsky NG, Smaldone MC, Sobczak ML, Kutikov A, Viterbo R, Horwitz EM (2014) “Impact of Obesity on Outcomes After Definitive Dose Escalated Intensity Modulated Radiation Therapy for Localized Prostate Cancer” Published in Cancer, 2015, PMID# 26033633

Zaorsky NG, Li T, Turaka A, Chen DYT, Horwitz EM, Buyyounouski MK. Interval to biochemical failure is prognostic for distant metastases after salvage radiation therapy for prostate cancer. Journal of Radiation Oncology. 2015.

Zaorsky NG, Palmer JD, Hurwitz MD, Keith SW, Dicker AP, Den RB. What is the ideal radiotherapy dose to treat prostate cancer?  A meta-analysis of biologically equivalent dose escalation.  Radiotherapy and Oncology. 2015. 2015 Jun;115(3):295-300. doi: 10.1016/j.radonc.2015.05.011.

Zaorsky NG, Meng MB, Deng L, Wang HH, Chao J, Zhao LJ, Yuan ZY, Ping W. Pericytes: a double-edged sword in cancer therapy.  Future Oncology. 2015;11(1):169-79.

Zaorsky NG, Hallman MA, Smaldone MC. Radiation therapy to the primary tumor in locally advanced prostate cancer is not “closing the barn door after the horse has bolted.” Annals of Translational Medicine. 2015.

Zaorsky NG, Horwitz EM. Chapter 43: Brachytherapy for prostate cancer. Prostate Cancer: Science and Clinical Practice. Mydlo JH, Godec CJ (Eds.). 399-412. ISBN: 9780128000779.

Zaorsky NG, Shaikh TA, Handorf E, Eastwick G, Hesney A, Scher ED, Jones RT, Showalter TN, Avkshtol V, Rice SR, Horwitz EM, Meyer JE. What are medical students in the United States learning about radiation oncology? Results of a multi-institutional survey. International Journal of Radiation Oncology Biology and Physics. 2015.

Zaorsky NG, Meng MB, Wang H, Jiang C, Qian D, Zhao L, Yuan Z, Ping W. Multimodality therapy is recommended for limited-stage combined small cell esophageal carcinoma.  Onco Targets Ther. 2015 Feb 13(8):437-44.

Zaorsky NG, Hurwitz MD, Dicker AP, Showalter TN, Den RB. Is robotic arm stereotactic body radiation therapy “virtual high dose rate brachytherapy” for prostate cancer?  An analysis of comparative effectiveness using published data. Expert Rev Med Devices. 2015 May;12(3):317-27.

Zaorsky NG, Showalter TN, Ezzel GA, Nguyen PL, Assimos DG, D’Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLauglin PW, Movsas B, Prestige BR, Taira AV, Vapiwala N, Davis BJ. American College of Radiology appropriateness criteria:  external beam radiation therapy treatment planning for clinically localized prostate cancer.   Int J Radiat Oncol Biol Phys.  2016.

Zaorsky NG, Showalter TN, Ezzel GA, Nguyen PL, Assimos DG, D’Amico AV, Gottschalk AR, Gustafson GS, Keole SR, Liauw SL, Lloyd S, McLauglin PW, Movsas B, Prestige BR, Taira AV, Vapiwala N, Davis BJ. Case vignettes for the American College of Radiology appropriateness criteria external beam radiation therapy treatment planning for clinically localized prostate cancer.   Int J Radiat Oncol Biol Phys.  2016.

 

2014... Expand

Connect with Fox Chase